I've been on it for a year, and I've lost about 70 pounds
But if you are taking a glucagon-like peptide-1 drug better known as GLP-1 for weight loss, the protocol for getting back on track may be different from missing a dose of antibiotics
The effect of GLP-1 receptor agonists on circulating inflammatory markers in type 2 diabetes patients: A systematic review and meta-analysis Zhu, Kai, et al (2023) Efficacy and safety of semaglutide in non-alcoholic fatty liver disease Gastalldeli, Amalia, et al
Thus, inadequate payer coverage will have a disproportionate impact on those demographics with greater obesity prevalence and lower incomes, further driving health inequity
This dose-response relationship has become one of the defining features of retatrutides current safety profile
The difference depends on whether the medication is being used with clinical oversight, clear dosing, appropriate monitoring, and a larger plan for metabolic health, muscle preservation, cardiovascular risk reduction, and long-term function